| abstract |
Disclosed are methods for treating, preventing, correcting and / or managing skin diseases or disorders characterized by hyperproliferation of the epidermis, keratosis, scleroderma, dermatovasculitis, pressure ulcers or epilepsy. Specific embodiments include an immunomodulatory compound or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, inclusion compound or prodrug thereof, alone or in combination with a second active agent. Administration. Specific second active agents are those that can affect or inhibit cell growth or proliferation, remove or ameliorate pressure ulcer scars, or reduce or correct wrinkles. In addition, pharmaceutical compositions, single unit dosage forms and kits suitable for use in the methods of the present invention are also disclosed. |